External Antiparasitic Vectra 3D. Pipettes for cats
In addition to irritating your cat's skin, a flea bite can also transmit disease. Treating it monthly with VECTRA Felis ensures that your cat receives the protection it deserves and prevents an infestation in your home.
Our unique applicator makes it easy to reach your cat's skin, ensuring that the product comes into contact with the cat's skin.
Prevent fleas from biting your cat, it dies within two hours of infestation.
Protect your home against flea eggs, larvae and pupae for 3 months.
A dose for all cats that can be used safely in small cats from 7 weeks (from 0.6kg).
Composition
per spot-on applicator:
Dinotefuran 423mg; pyriproxyfen 42.3 mg.
Pharmacological properties
External antiparasitic with dinotefuran and pyriproxyfen. It acts as an insecticide.
Dinotefuran is an insecticide that kills fleas on contact.
Pyriproxyfen is a photostable insect growth regulator (IGR). It works by contact and
prevents infestation in the environment of the treated animal.
Vectra® Felis kills fleas in all their phases.
Interactions and incompatibilities
Do not mix with any other veterinary medicine, and do not apply together with any other
veterinary medicinal product at the same time and in the same place.
Indications and target species
Cats: Treatment and prevention of infestation by fleas (Ctenocephalides felis).
One application prevents flea infestation for one month. It also prevents the multiplication of
fleas by inhibiting the appearance of fleas in the cat's environment for 3 months.
The veterinary medicinal product can be used as part of the treatment strategy for the
Control of flea allergy dermatitis (FAD) in cats.
contraindications
Do not use in cats or kittens weighing less than 0.6 kg. Side effects
Transient cosmetic effects such as wet hair and a dry white residue may be observed
at the point of application that can persist up to 7 days; however, these effects usually
they are no longer observed after 48 hours. These changes do not affect the safety or effectiveness of the
medicine.
On rare occasions, slight desquamation, transient erythema and alopecia have been observed, which
They usually go away on their own without treatment.
route of administration
Cutaneous use.
Pay your order securely with major credit cards: VISA, VISA Electron, 4B, or Mastercard.
You offers on a credit card discharged in your bank to operate in safe Internet shops.
You will receive your order on the shipping address you have chosen and you will be cashed to give it to you.
Securely pay your orders by indicating your mobile number and Bizum password.
Your order will be shipped when we receive the payment or transfer of the amount.
The unpaid order will be automatically deleted in 5 days.
You can make your payment in store to pick up your order.
(*) To pay with PayPal, Contrareembolso and Income/Bank Transfer minimum order will be 49€.
Ceva Santé Animale has been the company's fastest growing animal health in its first 10 years.
This puts us in ninth place worldwide in animal health, and the company was founded a few years ago, in 1999. Our expertise is in the fields of pharmacy and biology, where we have dedicated teams that aim to meet the specific demands of livestock, poultry, swine and pets. We continually strive to find better solutions for both existing and emerging diseases, which in turn improve animal health and productivity.
Our work goes beyond animal health. Today, a staggering 75% of all emerging human infectious diseases are of animal origin. Ceva is involved in combating the spread of infectious diseases that can be transmitted from wild or domestic animals and birds to humans, known as zoonosis diseases, including avian flu, brucellosis and Q-fever.
Ceva is in favor of contributing to the welfare and social programs worldwide. Our work ranges from research, development, production and supply of animal health products to the poorest livestock owners in the world, of which our SOS (Stamp Out Sleeping sickness) in Uganda is a good example, or the donation in the UK Canine Associations of Adaptil to make life less stressful for the dogs.
CEVA combines profitability with long-term growth.
Our work is divided into six major regions: Western Europe, Eastern Europe and Central (Turkey incl.), North America, Latin America, Africa / Middle East and Asia / Pacific.
We are present in 42 countries, where we work in more than 110 countries. We have 113 R & D centers, 21 production centers and over 3500 employees worldwide.